Abstract:Background: The development of drug resistance and the persistence of leukemia stem cells are major obstacles for the use of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML). The induction of autophagic death in tumor cells represents a new route for leukemia treatment. Our previous study showed that infection of CML cells with oncolytic viruses carrying the autophagy gene Beclin1 downregulated BCR/ABL protein expression and significantly increased the killing effect of the oncolytic viruses on CML cells via autophagy activation. However, the specific molecular mechanisms underlying the regulation of BCR/ABL and Beclin1-dependent CML cell killing remain unclear. Methods: A physical interaction between BCR/ABL and Beclin1 was characterized via GST-pulldown, co-IP and dual-luciferase reporter assays. Cell proliferation was examined via CCK-8 and clone formation assays. The expression levels of the related proteins were measured via Western blotting. Autophagosomes were observed under transmission electron microscopy. Lentiviral vectors carrying Atg7/UVRAG shRNA or the Beclin1 gene were used to modulate the expression levels of the indicated genes. Immunofluorescence were performed to examine colocalization of BCR/ABL and p62/SQSTM1. CD34(+)CD38(-) cells were isolated from bone marrow samples from CML patients via fluorescence-activated cell sorting. Results: In this study, we observed that Beclin1 directly interacts with BCR/ABL. Beclin1 inhibited the activity of the BCR/ABL promoter to downregulate the level of BCR/ABL protein and to promote the downstream colocalization of p62/SQSTM1 and BCR/ABL to autolysosomes for degradation via activation of the autophagy signaling pathway. In CML cell lines, primary cells and CD34(+)CD38(-) leukemia stem cells, Beclin1 overexpression significantly inhibited cell growth and proliferation and induced autophagy. Conclusion: Taken together, our results suggest that autophagy induction via Beclin1 overexpression might offer new approaches for treating TKI-resistant CML and for promoting the clearance of leukemia stem cells, both of which have important clinical implications.

BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy

Beclin 2 negatively regulates innate immune signaling and tumor development

Identification of Barkor As a Mammalian Autophagy-Specific Factor for Beclin 1 and Class III Phosphatidylinositol 3-Kinase.

Regulation of Beclin 1 in Autophagy.

Divergent Roles of BECN1 in LC3 Lipidation and Autophagosomal Function.

CD36 and LC3B initiated autophagy in B cells regulates the humoral immune response

Deciphering functional roles and interplay between Beclin1 and Beclin2 in autophagosome formation and mitophagy

Xbp1 Mrna Splicing Triggers An Autophagic Response In Endothelial Cells Through Beclin-1 Transcriptional Activation

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice

Beclin 1 regulates recycling endosome and is required for skin development in mice

Co-Chaperone Bag-1 Plays a Role in the Autophagy-Dependent Cell Survival through Beclin 1 Interaction

BECN2 (beclin 2)-mediated non-canonical autophagy in innate immune signaling and tumor development

Crystal Structure and Biochemical Analyses Reveal Beclin 1 As a Novel Membrane Binding Protein

Adipocyte-specific Beclin1 deletion impairs lipolysis and mitochondrial integrity in adipose tissue

Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses

Down-regulation of Beclin1 promotes direct cardiac reprogramming

Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation